Published on
Apr 18, 2025
5 Notable FDA Approvals From March Highlight Advancements Across Therapeutic Areas
March was a busy month for the FDA, with several drug approvals across diverse therapeutic areas, including Crohn disease, uncomplicated urinary tract infections (uUTIs), and muscle-invasive bladder cancer (MIBC). Here is a closer look at 5 notable FDA …
Source:
The American Journal of Managed Care
-
Neutral
